New Mesothelioma Drug Starts Trial
Verismo Therapeutics announced that is has received clearance of its new drug for ovarian cancer, cholangiocarcinoma, and, mesothelioma from the U.S. Food and Drug Administration (FDA) to initiate a first-in-human Phase 1 clinical trial of SynKIR-110. The first human trials...
Read More
Blood Test Can Accurately Diagnose Mesothelioma
Historically there have been only two ways to diagnose mesothelioma: histology and cytology. Histology tests tissue and cytology tests fluid. Both tests are often performed to determine if a patient has mesothelioma. Often, the patient is in an advanced stage...
Read More